Patents by Inventor Kefeng SUN

Kefeng SUN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF MARIBAVIR IN TREATMENT REGIMENS
    Publication number: 20260027141
    Abstract: Characterization of drug-drug interaction properties and pharmacological properties of maribavir is useful to inform potential drug-drug interactions and dosing strategies when administering with co-medications.
    Type: Application
    Filed: September 30, 2025
    Publication date: January 29, 2026
    Inventors: Heng SONG, Kefeng SUN, Matthew CROUTHAMEL, Grace CHEN, Andy Z. X. ZHU, Ingrid Nicolle MICHON, Howard James BURT, Zoe Elizabeth BARTER, Sibylle NEUHOFF
  • Use of maribavir in treatment regimens
    Patent number: 12447170
    Abstract: Characterization of drug-drug interaction properties and pharmacological properties of maribavir is useful to inform potential drug-drug interactions and dosing strategies when administering with co-medications.
    Type: Grant
    Filed: December 20, 2024
    Date of Patent: October 21, 2025
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Heng Song, Kefeng Sun, Matthew Crouthamel, Grace Chen, Andy Z. X. Zhu, Ingrid Nicolle Michon, Howard James Burt, Zoe Elizabeth Barter, Sibylle Neuhoff
  • Use of maribavir in treatment regimens
    Patent number: 12433907
    Abstract: Characterization of drug-drug interaction properties and pharmacological properties of maribavir is useful to inform potential drug-drug interactions and dosing strategies when administering with co-medications.
    Type: Grant
    Filed: December 20, 2024
    Date of Patent: October 7, 2025
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Heng Song, Kefeng Sun, Matthew Crouthamel, Grace Chen, Andy Z. X. Zhu, Ingrid Nicolle Michon, Howard James Burt, Zoe Elizabeth Barter, Sibylle Neuhoff
  • USE OF MARIBAVIR IN TREATMENT REGIMENS
    Publication number: 20250144124
    Abstract: Characterization of drug-drug interaction properties and pharmacological properties of maribavir is useful to inform potential drug-drug interactions and dosing strategies when administering with co-medications.
    Type: Application
    Filed: December 20, 2024
    Publication date: May 8, 2025
    Inventors: Heng SONG, Kefeng SUN, Matthew CROUTHAMEL, Grace CHEN, Andy Z. X. ZHU, Ingrid Nicolle MICHON, Howard James BURT, Zoe Elizabeth BARTER, Sibylle NEUHOFF
  • USE OF MARIBAVIR IN TREATMENT REGIMENS
    Publication number: 20250120995
    Abstract: Characterization of drug-drug interaction properties and pharmacological properties of maribavir is useful to inform potential drug-drug interactions and dosing strategies when administering with co-medications.
    Type: Application
    Filed: December 20, 2024
    Publication date: April 17, 2025
    Inventors: Heng SONG, Kefeng SUN, Matthew CROUTHAMEL, Grace CHEN, Andy Z. X. ZHU, Ingrid Nicolle MICHON, Howard James BURT, Zoe Elizabeth BARTER, Sibylle NEUHOFF
  • Use of maribavir in treatment regimens
    Patent number: 12213989
    Abstract: Characterization of drug-drug interaction properties and pharmacological properties of maribavir is useful to inform potential drug-drug interactions and dosing strategies when administering with co-medications.
    Type: Grant
    Filed: April 25, 2024
    Date of Patent: February 4, 2025
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Heng Song, Kefeng Sun, Matthew Crouthamel, Grace Chen, Andy Z. X. Zhu, Ingrid Nicolle Michon, Howard James Burt, Zoe Elizabeth Barter, Sibylle Neuhoff
  • USE OF MARIBAVIR IN TREATMENT REGIMENS
    Publication number: 20240285663
    Abstract: Characterization of drug-drug interaction properties and pharmacological properties of maribavir is useful to inform potential drug-drug interactions and dosing strategies when administering with co-medications.
    Type: Application
    Filed: April 25, 2024
    Publication date: August 29, 2024
    Inventors: Heng SONG, Kefeng SUN, Matthew CROUTHAMEL, Grace CHEN, Andy Z. X. ZHU, Ingrid Nicolle MICHON, Howard James BURT, Zoe Elizabeth BARTER, Sibylle NEUHOFF
  • USE OF MARIBAVIR IN TREATMENT REGIMENS
    Publication number: 20240156849
    Abstract: Characterization of drug-drug interaction properties and pharmacological properties of maribavir is useful to inform potential drug-drug interactions and dosing strategies when administering with co-medications.
    Type: Application
    Filed: December 29, 2023
    Publication date: May 16, 2024
    Applicants: Takeda Pharmaceuticals U.S.A., Inc, Certara USA, Inc.
    Inventors: Heng Song, Kefeng Sun, Matthew Crouthamel, Grace Chen, Andy Z.X. Zhu, Ingrid Nicolle Michon, Howard James Burt, Zoe Elizabeth Barter, Sibylle Neuhoff
  • GLP-2 FUSION POLYPEPTIDES AND USES FOR TREATING AND PREVENTING GASTROINTESTINAL CONDITIONS
    Publication number: 20200199192
    Abstract: Described are fusion proteins of GLP-2 with an Fc region of immunoglobulin. The GLP-2 and Fc regions are separated by a linker comprised of amino acids. The fusion proteins persist and remain active in the body for longer periods of time than GLP-2 itself. Methods are disclosed of using the fusion proteins to treat and prevent enterocutaneous fistulae, radiation damage to the gastrointestinal tract, obstructive jaundice, and short bowel syndrome.
    Type: Application
    Filed: August 21, 2018
    Publication date: June 25, 2020
    Applicant: SHIRE-NPS PHARMACEUTICALS, INC.
    Inventors: Clark PAN, Angela NORTON, Bettina STRACK-LOGUE, Kefeng SUN